8th January 2015
CloudTag (CTAG:LN), which develops personal performance monitoring for the professional sports and consumer wellbeing markets, is pleased to announce that it has appointed Amit Ben-Haim as Director of Corporate Development with immediate effect.
CloudTag has appointed Amit as an Executive Director of the Company on a full-time basis, to reflect the true potential of his contribution going forward in the next phase of the Company’s development. Amit will be involved in the on-going growth, development and expansion of the Company, both on a commercial and corporate basis.
Prior to this appointment, Amit was engaged as a Consultant to CloudTag, making introductions to investors and other partners in the areas of finance, technology and consumer health and wellbeing. He has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms, which was sold in 2000 to NASDAQ-listed Comverse Inc.
Pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies, the following information is disclosed:
Amit Ben-Haim, aged 54, is or has been a director or member of the following companies or partnerships during the previous five years:
Current Directorships or Partnerships
- SB Corporate Finance Partners Limited
Past Directorships within the last 5 years
- Balfour Electronics Limited
- Essentium Group Limited
- Golden Bridge Services Limited
- Novum Wines Limited
Mr Ben-Haim is interested in 6,666,667 ordinary shares of 0.25p each in the Company, representing 4.02% of the issued share capital of the Company. There is no further information to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules for Companies.
Commenting, Tony Reeves, Non-Executive Chairman: “I am delighted that Amit has agreed to join the Board of Directors and we look forward to him becoming an integral part of the business going forward.”